Search

Hyoscyamine

[A228713] Hyoscyamine is used for a wide variety of treatments and therapeutics due to its antimuscarinic properties.

Ketamine

Ketamine is an NMDA receptor antagonist with a potent anesthetic effect.[A31869] It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. … It was FDA approved in 1970, and from there, it has been used as an anesthetic for children or patients undergoing minor surgeries but mainly for veterinary purposes.[L1332]

Calcium ascorbate

Lapatinib

Lapatinib is an anti-cancer drug developed by GlaxoSmithKline (GSK) as a treatment for solid tumours such as breast and lung cancer. … It was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug capecitabine.

PI-166

PI-166 is a small organic compound with specific avidity to liver cancer cells.

Rilzabrutinib

Rilzabrutinib is an oral, reversible, covalent inhibitor of Bruton's tyrosine kinase [A259078, L53738] that was approved by the FDA on August 29, 2025, for the treatment of persistent and chronic immune … [L53743] ITP is an autoimmune disorder characterized by low platelet count.

Peanut oil

[A33169] Under the FDA, peanut oil is categorized as an approved inactive ingredient for its use in drug products. … The kernels are consumed roasted but a large percentage is used for the production of vegetable oil.

Miglustat

It inhibits the enzyme glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids. … Miglustat was first developed as an anti-HIV agent in the 1990s.

Peramivir

for no more than two days. … Peramivir is an antiviral agent developed by Biocryst Pharmaceuticals to treat influenza A/B.